Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
1,278 rows where has_known_aptamer = 0, in_cev_map = 1 and tier = "Tier 1" sorted by priority_score descending
This data as json, CSV (advanced)
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P01911 | HLA-DRB1 | HLA class II histocompatibility antigen, DRB1 beta chain | Tier 1 | 0.84 | 100 | 88.44 | 0 | 0 | 0 | 0 | 1 | rheumatoid arthritis | 0.40051584219092445 | ||||
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | Tier 1 | 0.805 | 22 | 80.12 | 1 | 0 | 0 | 0 | 1 | dicarboxylic aminoaciduria | 0.6273449709512636 | ||||
| P00488 | F13A1 | Coagulation factor XIII A chain | Tier 1 | 0.799 | 15 | 90.88 | 1 | 0 | 0 | 0 | 1 | Factor XIII subunit A deficiency | 0.7939842013132387 | ||||
| P06731 | CEACAM5 | Cell adhesion molecule CEACAM5 | Tier 1 | 0.795 | 6 | 87.12 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.45156128674958135 | ||||
| P35555 | FBN1 | Fibrillin-1 | Tier 1 | 0.78 | 11 | 0 | 0 | 0 | 0 | 1 | Marfan syndrome | 0.8969300970597663 | |||||
| P02671 | FGA | Fibrinogen alpha chain | Tier 1 | 0.77 | 40 | 60.34 | 0 | 0 | 0 | 0 | 1 | familial dysfibrinogenemia | 0.7947496460990987 | ||||
| P03951 | F11 | Coagulation factor XI | Tier 1 | 0.77 | 100 | 86.88 | 0 | 0 | 0 | 0 | 1 | factor XI deficiency | 0.841884208404384 | ||||
| P02747 | C1QC | Complement C1q subcomponent subunit C | Tier 1 | 0.762 | 11 | 80.56 | 1 | 0 | 0 | 0 | 1 | C1Q deficiency | 0.6233532074390745 | ||||
| Q02817 | MUC2 | Mucin-2 | Tier 1 | 0.76 | 12 | 1 | 0 | 0 | 0 | 1 | |||||||
| P07360 | Tier 1 | 0.755 | 15 | 89.75 | 1 | 0 | 0 | 0 | 1 | complement deficiency | 0.3695798546847018 | ||||||
| P55899 | FCGRT | IgG receptor FcRn large subunit p51 | Tier 1 | 0.752 | 31 | 85.0 | 1 | 0 | 0 | 0 | 1 | Myasthenia gravis | 0.5932721106551206 | ||||
| Q9BY67 | CADM1 | Cell adhesion molecule 1 | Tier 1 | 0.734 | 2 | 80.56 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.442731358018962 | ||||
| Q99497 | PARK7 | Parkinson disease protein 7 | Tier 1 | 0.723 | 88 | 98.44 | 0 | 0 | 0 | 0 | 1 | Young adult-onset Parkinsonism | 0.7264878745993893 | ||||
| P11215 | ITGAM | Integrin alpha-M | Tier 1 | 0.72 | 30 | 86.25 | 1 | 0 | 0 | 0 | 1 | systemic lupus erythematosus | 0.30502849242596436 | ||||
| Q9NV96 | TMEM30A | Cell cycle control protein 50A | Tier 1 | 0.71 | 33 | 89.5 | 1 | 0 | 0 | 0 | 1 | atrial fibrillation | 0.31177132249681394 | ||||
| P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | Tier 1 | 0.708 | 100 | 88.06 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.48417012135481613 | ||||
| O60486 | PLXNC1 | Plexin-C1 | Tier 1 | 0.703 | 4 | 79.06 | 1 | 0 | 0 | 0 | 1 | asthma | 0.532656225351722 | ||||
| P08473 | MME | Neprilysin | Tier 1 | 0.699 | 16 | 96.19 | 0 | 0 | 0 | 0 | 1 | Charcot-Marie-Tooth disease axonal type 2T | 0.7912653398252156 | ||||
| Q92187 | ST8SIA4 | CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase | Tier 1 | 0.69 | 3 | 86.44 | 0 | 0 | 0 | 0 | 1 | systemic lupus erythematosus | 0.43832763677821385 | ||||
| Q8NBJ9 | Tier 1 | 0.688 | 7 | 80.25 | 1 | 0 | 0 | 0 | 1 | hypothyroidism | 0.32686531914177924 | ||||||
| O95399 | UTS2 | Urotensin-2 | Tier 1 | 0.685 | 2 | 58.44 | 0 | 0 | 0 | 0 | 1 | hair color | 0.35316475479030335 | ||||
| P63092 | GNAS | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Tier 1 | 0.683 | 100 | 91.31 | 1 | 0 | 0 | 0 | 1 | pseudohypoparathyroidism type 1A | 0.826829760867455 | ||||
| Q14213 | Tier 1 | 0.683 | 4 | 87.62 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.42776938116451996 | ||||||
| Q99584 | S100A13 | Protein S100-A13 | Tier 1 | 0.681 | 12 | 80.81 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.41302685279153983 | ||||
| Q9UNN8 | PROCR | Endothelial protein C receptor | Tier 1 | 0.68 | 13 | 86.44 | 1 | 0 | 0 | 0 | 1 | venous thromboembolism | 0.5497662282245215 | ||||
| Q9HBI1 | PARVB | Beta-parvin | Tier 1 | 0.68 | 3 | 81.75 | 0 | 0 | 0 | 0 | 1 | thyroiditis | 0.28021156500366357 | ||||
| O00602 | FCN1 | Ficolin-1 | Tier 1 | 0.675 | 7 | 84.94 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.351581018821974 | ||||
| Q9UK55 | SERPINA10 | Protein Z-dependent protease inhibitor | Tier 1 | 0.672 | 4 | 86.75 | 0 | 0 | 0 | 0 | 1 | macular degeneration | 0.3247169581531489 | ||||
| P02749 | APOH | Beta-2-glycoprotein 1 | Tier 1 | 0.67 | 14 | 93.12 | 0 | 0 | 0 | 0 | 1 | atrial fibrillation | 0.5456247991985232 | ||||
| P06703 | S100A6 | Protein S100-A6 | Tier 1 | 0.67 | 6 | 87.19 | 0 | 0 | 0 | 0 | 1 | neoplasm | 0.10449825238323361 | ||||
| P78552 | IL13RA1 | Interleukin-13 receptor subunit alpha-1 | Tier 1 | 0.67 | 4 | 81.56 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.48627783096767857 | ||||
| P54762 | EPHB1 | Ephrin type-B receptor 1 | Tier 1 | 0.665 | 8 | 83.62 | 0 | 0 | 0 | 0 | 1 | medullary thyroid gland carcinoma | 0.5204553830376101 | ||||
| Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | Tier 1 | 0.66 | 17 | 91.44 | 1 | 0 | 0 | 0 | 1 | lymphoma | 0.37253457492562664 | ||||
| Q7L2H7 | EIF3M | Eukaryotic translation initiation factor 3 subunit M | Tier 1 | 0.66 | 0 | 55.28 | 0 | 0 | 0 | 0 | 1 | Hernia | 0.2963310523049043 | ||||
| P05543 | SERPINA7 | Thyroxine-binding globulin | Tier 1 | 0.655 | 9 | 87.06 | 0 | 0 | 0 | 0 | 1 | neoplasm | 0.09631257418600654 | ||||
| P20701 | ITGAL | Integrin alpha-L | Tier 1 | 0.655 | 41 | 82.62 | 0 | 0 | 0 | 0 | 1 | psoriasis | 0.5899795223699872 | ||||
| Q5JWF2 | GNAS | Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas | Tier 1 | 0.653 | 9 | 56.72 | 1 | 0 | 0 | 0 | 1 | pseudohypoparathyroidism type 1A | 0.826829760867455 | ||||
| P54764 | Tier 1 | 0.652 | 17 | 83.5 | 0 | 0 | 0 | 0 | 1 | medullary thyroid gland carcinoma | 0.5195314334008982 | ||||||
| P04746 | AMY2A | Pancreatic alpha-amylase | Tier 1 | 0.65 | 51 | 96.75 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.5997984923419163 | ||||
| Q13936 | CACNA1C | Voltage-dependent L-type calcium channel subunit alpha-1C | Tier 1 | 0.65 | 33 | 61.94 | 1 | 0 | 0 | 0 | 1 | Timothy syndrome | 0.8227725490420764 | ||||
| P62491 | RAB11A | Ras-related protein Rab-11A | Tier 1 | 0.64 | 30 | 87.19 | 0 | 0 | 0 | 0 | 1 | Intellectual disability | 0.4852051194358318 | ||||
| P26447 | S100A4 | Protein S100-A4 | Tier 1 | 0.636 | 17 | 86.44 | 0 | 0 | 0 | 0 | 1 | Alzheimer disease | 0.36416197951415524 | ||||
| P54289 | CACNA2D1 | Voltage-dependent calcium channel subunit alpha-2/delta-1 | Tier 1 | 0.635 | 30 | 86.56 | 1 | 0 | 0 | 0 | 1 | Seizure | 0.6942469435259896 | ||||
| P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | Tier 1 | 0.635 | 38 | 62.41 | 1 | 0 | 0 | 0 | 1 | immunodeficiency 25 | 0.7436838111879828 | ||||
| Q96A54 | ADIPOR1 | Adiponectin receptor protein 1 | Tier 1 | 0.632 | 3 | 83.25 | 0 | 0 | 0 | 0 | 1 | Retinal dystrophy | 0.17324768030468937 | ||||
| Q16555 | DPYSL2 | Dihydropyrimidinase-related protein 2 | Tier 1 | 0.63 | 15 | 90.25 | 1 | 0 | 0 | 0 | 1 | hypertension | 0.4377422749119531 | ||||
| O14939 | PLD2 | Phospholipase D2 | Tier 1 | 0.63 | 6 | 88.94 | 0 | 0 | 0 | 0 | 1 | systemic lupus erythematosus | 0.22499036596471594 | ||||
| Q15113 | PCOLCE | Procollagen C-endopeptidase enhancer 1 | Tier 1 | 0.63 | 4 | 79.56 | 0 | 0 | 0 | 0 | 1 | hair color | 0.09954732229482598 | ||||
| P49790 | NUP153 | Nuclear pore complex protein Nup153 | Tier 1 | 0.63 | 12 | 43.59 | 1 | 0 | 0 | 0 | 1 | HIV infection | 0.5431773609684529 | ||||
| O75970 | MPDZ | Multiple PDZ domain protein | Tier 1 | 0.628 | 9 | 63.72 | 0 | 0 | 0 | 0 | 1 | Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies | 0.7761660121864681 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;